We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+19.66%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$870M
AUM Growth
-$294M
(-25%)
Cap. Flow
-$431M
Cap. Flow
% of AUM
-49.59%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
125
New
9
Increased
9
Reduced
74
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$7.93M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$6.31M |
| 3 |
ICU Medical
ICUI
|
+$5.89M |
| 4 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
+$5.51M |
| 5 |
EVRI
Everi Holdings
EVRI
|
+$5.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$18.2M |
| 2 |
QUOT
Quotient Technology Inc
QUOT
|
+$14.9M |
| 3 |
INXN
Interxion Holding N.V.
INXN
|
+$14.3M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$12.2M |
| 5 |
Medifast
MED
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32% |
| 2 | Technology | 14.68% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QUOT
1
DELISTED
Quotient Technology Inc
QUOT
| $31.8M | 3.65% |
3,221,416
-1,556,840
| -33% | -$14.9M |
|
|
INXN
2
DELISTED
Interxion Holding N.V.
INXN
| $26.2M | 3.02% |
312,893
-170,985
| -35% | -$14.3M |
|
3
Ligand Pharmaceuticals
LGND
$5.76B
| $24.7M | 2.84% |
379,690
-167,821
| -31% | -$11.2M |
|
4
Cerus
CERS
$431M
| $22.3M | 2.56% |
5,284,441
-1,558,452
| -23% | -$6.72M |
|
|
INFN
5
DELISTED
Infinera Corporation Common Stock
INFN
| $20.8M | 2.39% |
2,618,986
-1,411,510
| -35% | -$8.68M |
|
|
SNCR
6
DELISTED
Synchronoss Technologies
SNCR
| $17.8M | 2.05% |
416,450
-163,174
| -28% | -$7.24M |
|
7
Evolent Health
EVH
$348M
| $17.6M | 2.02% |
1,942,034
-342,298
| -15% | -$2.78M |
|
|
TVTY
8
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $17.2M | 1.97% |
843,351
+10,371
| +1% | +$194K |
|
|
IVC
9
DELISTED
Invacare Corporation
IVC
| $16.8M | 1.94% |
1,867,396
-1,220,843
| -40% | -$10.3M |
|
|
MAXR
10
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $16.2M | 1.87% |
1,035,249
-557,499
| -35% | -$5.79M |
|
11
OneSpan
OSPN
$574M
| $15.4M | 1.78% |
901,789
-460,614
| -34% | -$7.83M |
|
|
PLYA
12
DELISTED
Playa Hotels & Resorts
PLYA
| $14.7M | 1.69% |
1,748,676
-82,477
| -5% | -$641K |
|
13
Gogo Inc
GOGO
$565M
| $13.5M | 1.55% |
2,103,935
-1,127,435
| -35% | -$6.56M |
|
14
Iridium Communications
IRDM
$5.02B
| $13.2M | 1.52% |
535,087
-291,553
| -35% | -$6.99M |
|
15
PTC Therapeutics
PTCT
$5.64B
| $12.5M | 1.43% |
259,725
-106,911
| -29% | -$4.54M |
|
16
Pacira BioSciences
PCRX
$1.04B
| $12.3M | 1.41% |
271,182
-186,455
| -41% | -$7.92M |
|
17
NN Inc
NNBR
$255M
| $12.1M | 1.39% |
1,306,440
-30,926
| -2% | -$248K |
|
18
MaxLinear
MXL
$6.06B
| $11.7M | 1.35% |
551,478
-290,222
| -34% | -$6.02M |
|
|
LMNX
19
DELISTED
Luminex Corp
LMNX
| $11.5M | 1.32% |
496,222
-199,496
| -29% | -$4.12M |
|
20
Halozyme
HALO
$9.79B
| $11.3M | 1.3% |
638,870
-119,683
| -16% | -$2.07M |
|
|
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $11.3M | 1.29% |
90,804
-70,602
| -44% | -$6.32M |
|
|
WAAS
22
DELISTED
AquaVenture Holdings Limited
WAAS
| $11.2M | 1.28% |
411,811
-185,626
| -31% | -$3.94M |
|
23
Churchill Downs
CHDN
$5.88B
| $11.1M | 1.28% |
162,236
-86,388
| -35% | -$5.63M |
|
|
PTLA
24
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.1M | 1.28% |
464,406
+33,581
| +8% | +$926K |
|
25
Surgery Partners
SGRY
$2.01B
| $11M | 1.27% |
703,814
-662,927
| -49% | -$7.52M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Elk Creek Partners held 125 positions worth $870M, down 25% from $1.16B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Elk Creek Partners withdrew a net $431M in Q4 2019, closing 33 positions and reducing 74 holdings. Its most notable exit was Exact Sciences, an estimated $12.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Elk Creek Partners opened a new position in Terminix Global Holdings, Inc. worth $7.21M.
- Elk Creek Partners's largest Q4 2019 buy was Terminix Global Holdings, Inc.: 186,365 shares worth $7.21M.
- Elk Creek Partners added most to ViewRay, Inc. in Q4 2019, an estimated $2.54M increase.
- Elk Creek Partners's biggest Q4 2019 reduction was Clovis Oncology, Inc., cutting an estimated $18.2M.
- Elk Creek Partners fully exited Exact Sciences in Q4 2019, selling an estimated $12.2M.
- Elk Creek Partners's ten largest holdings make up 24% of its $870M portfolio in Q4 2019.
- Elk Creek Partners opened 9 new positions and closed 33 in Q4 2019.
- Elk Creek Partners's portfolio value fell 25% quarter-over-quarter to $870M.
Based on Elk Creek Partners's 13F filing for Q4 2019, filed 14 Feb 2020.